These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Percutaneous left atrial appendage closure is not ready for routine clinical use. Mandrola J; Foy A; Naccarelli G Heart Rhythm; 2018 Feb; 15(2):298-301. PubMed ID: 29030233 [No Abstract] [Full Text] [Related]
7. Closure of Left Atrial Appendage With Persistent Distal Thrombus Using an Amplatzer Amulet Occluder. Lange M; Bültel H; Weglage H; Löffeld P; Wichter T J Invasive Cardiol; 2016 Sep; 28(9):E75-6. PubMed ID: 27591691 [TBL] [Abstract][Full Text] [Related]
8. Computed Tomography-X Ray Fusion in Left Atrial Appendage Closure. Barreiro-Pérez M; Cruz-González I; Sánchez PL Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):867. PubMed ID: 28274702 [No Abstract] [Full Text] [Related]
9. Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation. Khan F; Ramirez FD; Hibbert B CMAJ; 2018 Oct; 190(41):E1227-E1230. PubMed ID: 30322987 [No Abstract] [Full Text] [Related]
10. Watchman FLX: the initial Polish experience with a new device for left atrial appendage occlusion. Grygier M; Markiewicz A; Araszkiewicz A; Babicz-Sadowska A; Płaksej R; Komosa A; Trojnarska O; Lesiak M Kardiol Pol; 2020 Mar; 78(3):240-242. PubMed ID: 32024807 [No Abstract] [Full Text] [Related]
11. Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis. Schmidt B; Chun KRJ J Am Coll Cardiol; 2022 Aug; 80(5):484-485. PubMed ID: 35902170 [No Abstract] [Full Text] [Related]
13. Brain natriuretic peptide levels variation after left atrial appendage occlusion. Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Computed Tomography for Left Atrial Appendage Occlusion: Acquisition, Analysis, Advantages, and Limitations. Korsholm K; Jensen JM; Nielsen-Kudsk JE Interv Cardiol Clin; 2018 Apr; 7(2):229-242. PubMed ID: 29526291 [TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation. Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592 [TBL] [Abstract][Full Text] [Related]
16. Cardiac magnetic resonance for following-up device-related thrombosis after percutaneous left atrial appendage occlusion. Obayashi Y; Kawai Miyake K; Shiomi H Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):e39. PubMed ID: 36512469 [No Abstract] [Full Text] [Related]
17. Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation. Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Gras D; Mansourati J; Deharo JC; Montalescot G; Defaye P J Am Coll Cardiol; 2019 May; 73(20):2638-2640. PubMed ID: 31118155 [No Abstract] [Full Text] [Related]
18. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation. Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803 [TBL] [Abstract][Full Text] [Related]
19. First-in-human experience with the Cardia Ultraseal left atrial appendage closure device: The feasibility study. Sabiniewicz R; Hiczkiewicz J; Wańczura P; Stecko W; Curzytek A Cardiol J; 2016; 23(6):652-654. PubMed ID: 27976795 [No Abstract] [Full Text] [Related]
20. Sealing a Multilobe Left Atrial Appendage With Kissing-Watchman Technique. Zeng J; Lu C; Huang H J Invasive Cardiol; 2020 Jan; 32(1):E17. PubMed ID: 31893509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]